Search - tctmd.com

Displaying 141 - 160 of 323

Sort: Relevancy | Date

Presentation TCT 2013

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Presenter: Henrique Carvalho

October 30, 2013

Presentation TCT 2013

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

Presentation TCT 2013

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

Case #1: Left Ventricular Hypertrophy Regression and Improved Glycemic Control

Presenter: Pedro de Araujo Goncalves

October 30, 2013

Presentation TCT 2013

Are Sham Controls Needed for Future Renal Denervation Studies?

Presenter: Ajay Kirtane

October 30, 2013

Presentation TCT 2013

TCT-66. Risk stratification after endovascular treatment in claudicant patients with Iliofemoral artery disease

Presenter: Miura Takashi

October 29, 2013

Presentation TCT 2013

TCT-63. Drug-Coated Balloon (DCB) for Peripheral Arteries: Postdilatation of Nitinolstents with DCB or plain balloon in the superficial femoral artery – Interim results of the...

Presenter: Karl-Ludwig Schulte

October 29, 2013

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

Presenter: Petr Neuzil

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

Presenter: Stephen Worthley

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

Presentation TCT 2013

Stenting of the Renal Artery: Avoiding and Treating Complications

Presenter: Michel Henry

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Medical Therapy: Still the First Choice

Presenter: Darrel Francis

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Presenter: Satya Reddy Atmakuri

October 28, 2013

Presentation TCT 2013

Didactic(5)

Presenter: Lynne Hinterbuchner

October 28, 2013

Advertisement

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

Case #1: Left Ventricular Hypertrophy Regression and Improved Glycemic Control

Are Sham Controls Needed for Future Renal Denervation Studies?

TCT-66. Risk stratification after endovascular treatment in claudicant patients with Iliofemoral artery disease

TCT-63. Drug-Coated Balloon (DCB) for Peripheral Arteries: Postdilatation of Nitinolstents with DCB or plain balloon in the superficial femoral artery – Interim results of the...

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Stenting of the Renal Artery: Avoiding and Treating Complications

Renal Denervation: Ready for Primetime?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Medical Therapy: Still the First Choice

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Didactic(5)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content